Browsing Centre for Immunobiology by Subject "ART-naive"
Now showing items 1-1 of 1
-
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
(Wolters Kluwer Health, Inc, 2020-04-01)